
1. j trop med hyg. 2014 may;90(5):840-5. doi: 10.4269/ajtmh.13-0214. epub 2014
mar 10.

molecular analysis chloroquine sulfadoxine-pyrimethamine
resistance-associated alleles plasmodium falciparum isolates nicaragua.

sridaran s(1), rodriguez b, soto am, macedo de oliveira a, udhayakumar v.

author information: 
(1)malaria branch, division parasitic diseases malaria, center global 
health, centers disease control prevention, atlanta, georgia; atlanta
research education foundation, decatur, georgia; national reference and
diagnosis center, ministry health, managua, nicaragua; pan american health
organization, managua, nicaragua.

chloroquine (cq) used first-line therapy treatment plasmodium 
falciparum malaria nicaragua. investigated prevalence molecular
markers associated cq sulfadoxine-pyrimethamine (sp) resistance p.
falciparum isolates obtained north atlantic autonomous region of
nicaragua. blood spots study made available cq sp drug
efficacy trial conducted 2005 also surveillance study performed 
2011. polymorphisms p. falciparum cq resistance transporter, dihydrofolate
reductase, dihydropteroate synthase gene loci associated with
resistance cq, pyrimethamine, sulfadoxine, respectively, detected 
dna sequencing. 2005 dataset, 2 53 isolates cq resistance
allele (cviet), 2 52 pyrimethamine resistance allele, 1 49 
sulfadoxine resistance allele. 2011 dataset, none 45 isolates analyzed 
had cq sp resistance alleles.

doi: 10.4269/ajtmh.13-0214 
pmcid: pmc4015575
pmid: 24615126  [indexed medline]

